Permanent explantation of implantable cardioverter defibrillators

PACE - Pacing and Clinical Electrophysiology

Volumn 23, Issue 12 I, 2000, Pages 2024-2029

  Geist, Michael ^a,b   Newman, David ^a,b   Greene, Mary ^a,b   Paquette, Miney ^a,b   Dorian, Paul ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Explanted devices; Implantable cardioverter defibrillator; Ventricular arrhythmias

Indexed keywords

AMIODARONE; ATENOLOL; METOPROLOL; SOTALOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEFIBRILLATOR; EXPLANT; FEMALE; HEART VENTRICLE ARRHYTHMIA; HUMAN; INFECTION; MALE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0034494555     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2000.tb00771.x     Document Type: Article

References (33)

1. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
2. Prospective trials of implantable cardioverter defibrillators versus drugs: Are they addressing the right question?
3. Infections of implantable cardioverter defibrillators: Approach to management
4. Postoperative implantable cardioverter defibrillator: Clinical presentation and use of the gallium scan in diagnosis
5. Infections in implantable cardioverter defibrillator patients
6. Management of infected implantable cardiac defibrillators
7. The treatment of patients with infected implantable cardioverter-defibrillator systems
8. Psychiatric syndromes in patients with the automatic internal cardioverter defibrillator: Anxiety, psychological dependence, abuse, and withdrawal
9. Fate of explanted patients
10. Causes and consequences of discontinuation of the implantable cardioverter-defibrillator therapy in non-terminally ill patients
11. Clinical outcome following ICD removal
12. Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator
13. Long-term outcome with the automatic implantable cardioverter-defibrillator
14. Discontinuing an implantable cardioverter defibrillator as a life-sustaining treatment
15. Discontinuation of IDC therapy: How often and why?
16. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator
17. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: An international multicenter study
18. Bronchoenteric fistula from an infected internal cardioverter defibrillator
19. Clinical experience with the implantable cardioverter defibrillator
20. Infections after cardioverter-defibrillator implantation: Observations in 335 patients over 10 years
21. Complications of implantable cardioverter defibrillator therapy: Follow-up of 241 patients
22. Surgical coronary revascularization in survivors of prehospital cardiac arrest: Its effect on inducible ventricular arrhythmias and long term survival
23. Prophylactic use of implanted defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery
24. Incidence of implantable defibrillator discharges after coronary revascularization in survivors of ischemic sudden cardiac death
25. Survival of patients who have received appropriate shocks from their implantable defibrillator
26. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators
27. Long-term reproducibility of ventricular tachycardia induction in patients with implantable cardioverter/defibrillators. Serial noninvasive studies
28. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy
29. Italian multicenter clinical experience with endocardial defibrillation: Acute and long-term results in 307 patients
30. Influence of clinical characteristics and shock occurrence ICD patient outcome: A multicenter report
31. Predictors of automatic implantable cardioverter defibrillator discharge for life threatening arrhythmias
32. Predictors of outcome in patients with implantable transvenous cardioverter defibrillators
33. Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular tachycardia or ventricular fibrillation